Cambridge, MA, United States of America

Anne-Gaëlle Radenac

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sanofi. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Gaëlle Radenac. Retrieved from https://idiyas.com/inventor/anne-gaelle-radenac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Anne-Gaëlle Radenac

Introduction

Anne-Gaëlle Radenac is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of data processing systems, particularly in the context of drug indications. His work is characterized by a blend of technology and healthcare, aiming to improve patient outcomes through innovative solutions.

Latest Patents

Anne-Gaëlle Radenac holds 1 patent for his invention titled "Data processing systems and methods for identifying new indications for drugs." This patent describes a system that utilizes computer-readable memory and machine learning models to analyze medical records. The system is designed to identify new drug indications by processing data from a diverse set of patients, grouping them based on specific characteristics, and analyzing these groups to uncover relevant patient insights.

Career Highlights

Radenac's career is marked by his role at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in drug development and patient care. His expertise in data processing and machine learning has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Anne-Gaëlle Radenac has collaborated with notable colleagues, including Paul Bryce and Emanuele De Rinaldis. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in healthcare.

Conclusion

Anne-Gaëlle Radenac exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of technology in improving healthcare outcomes. His work continues to inspire future advancements in drug development and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…